Document
false--12-31Q120190000055785falseLarge Accelerated FilerKIMBERLY CLARK CORPfalse640000001.001.030.022021-03-310 0000055785 2019-01-01 2019-03-31 0000055785 kmb:A2018GlobalRestructuringProgramMember 2019-01-01 2019-03-31 0000055785 2018-01-01 2018-03-31 0000055785 2019-04-15 0000055785 2018-12-31 0000055785 2019-03-31 0000055785 2017-12-31 0000055785 2018-03-31 0000055785 kmb:KCArgentinaMember us-gaap:SalesMember 2019-01-01 2019-03-31 0000055785 kmb:KCArgentinaMember us-gaap:SalesMember 2018-01-01 2018-03-31 0000055785 kmb:A2018GlobalRestructuringProgramMember 2017-12-31 0000055785 kmb:WorkforcereductionsandotherexitcostsMember kmb:A2018GlobalRestructuringProgramMember 2018-01-01 2018-03-31 0000055785 kmb:A2018GlobalRestructuringProgramMember 2018-01-01 2018-03-31 0000055785 kmb:WorkforcereductionsandotherexitcostsMember kmb:A2018GlobalRestructuringProgramMember 2019-01-01 2019-03-31 0000055785 kmb:A2018GlobalRestructuringProgramMember 2019-03-31 0000055785 kmb:A2018GlobalRestructuringProgramMember 2018-12-31 0000055785 kmb:A2018GlobalRestructuringProgramMember 2018-03-31 0000055785 kmb:AfterTaxMember srt:MaximumMember kmb:A2018GlobalRestructuringProgramMember us-gaap:ScenarioForecastMember 2020-12-31 0000055785 kmb:AfterTaxMember srt:MinimumMember kmb:A2018GlobalRestructuringProgramMember us-gaap:ScenarioForecastMember 2020-12-31 0000055785 us-gaap:AccountsPayableAndAccruedLiabilitiesMember kmb:A2018GlobalRestructuringProgramMember 2018-03-31 0000055785 kmb:AfterTaxMember srt:MinimumMember kmb:A2018GlobalRestructuringProgramMember us-gaap:ScenarioForecastMember 2019-12-31 0000055785 kmb:BeforeTaxMember kmb:A2018GlobalRestructuringProgramMember 2018-01-01 2019-03-31 0000055785 kmb:AfterTaxMember kmb:A2018GlobalRestructuringProgramMember 2018-01-01 2019-03-31 0000055785 kmb:BeforeTaxMember srt:MinimumMember kmb:A2018GlobalRestructuringProgramMember us-gaap:ScenarioForecastMember 2019-12-31 0000055785 srt:MaximumMember kmb:CashChargesMember kmb:A2018GlobalRestructuringProgramMember us-gaap:ScenarioForecastMember 2020-12-31 0000055785 kmb:BeforeTaxMember srt:MaximumMember kmb:NoncashchargesMember kmb:A2018GlobalRestructuringProgramMember us-gaap:ScenarioForecastMember 2020-12-31 0000055785 kmb:BeforeTaxMember srt:MaximumMember kmb:A2018GlobalRestructuringProgramMember us-gaap:ScenarioForecastMember 2019-12-31 0000055785 srt:MinimumMember kmb:CashChargesMember kmb:A2018GlobalRestructuringProgramMember us-gaap:ScenarioForecastMember 2020-12-31 0000055785 us-gaap:OtherNoncurrentLiabilitiesMember kmb:A2018GlobalRestructuringProgramMember 2018-03-31 0000055785 kmb:AfterTaxMember srt:MaximumMember kmb:A2018GlobalRestructuringProgramMember us-gaap:ScenarioForecastMember 2019-12-31 0000055785 kmb:BeforeTaxMember srt:MaximumMember kmb:A2018GlobalRestructuringProgramMember us-gaap:ScenarioForecastMember 2020-12-31 0000055785 srt:MinimumMember kmb:A2018GlobalRestructuringProgramMember us-gaap:ScenarioForecastMember 2018-01-01 2020-12-31 0000055785 us-gaap:OtherNoncurrentLiabilitiesMember kmb:A2018GlobalRestructuringProgramMember 2019-03-31 0000055785 kmb:BeforeTaxMember srt:MinimumMember kmb:A2018GlobalRestructuringProgramMember us-gaap:ScenarioForecastMember 2020-12-31 0000055785 srt:MaximumMember kmb:A2018GlobalRestructuringProgramMember us-gaap:ScenarioForecastMember 2018-01-01 2020-12-31 0000055785 kmb:BeforeTaxMember srt:MinimumMember kmb:NoncashchargesMember kmb:A2018GlobalRestructuringProgramMember us-gaap:ScenarioForecastMember 2020-12-31 0000055785 us-gaap:AccountsPayableAndAccruedLiabilitiesMember kmb:A2018GlobalRestructuringProgramMember 2019-03-31 0000055785 kmb:BeforeTaxMember kmb:MarketingResearchAndGeneralExpensesMember kmb:A2018GlobalRestructuringProgramMember 2019-01-01 2019-03-31 0000055785 kmb:BeforeTaxMember us-gaap:OtherIncomeMember kmb:A2018GlobalRestructuringProgramMember 2018-01-01 2018-03-31 0000055785 kmb:BeforeTaxMember us-gaap:CostOfSalesMember kmb:A2018GlobalRestructuringProgramMember 2019-01-01 2019-03-31 0000055785 kmb:BeforeTaxMember us-gaap:CostOfSalesMember kmb:A2018GlobalRestructuringProgramMember 2018-01-01 2018-03-31 0000055785 kmb:BeforeTaxMember kmb:MarketingResearchAndGeneralExpensesMember kmb:A2018GlobalRestructuringProgramMember 2018-01-01 2018-03-31 0000055785 kmb:AfterTaxMember kmb:A2018GlobalRestructuringProgramMember us-gaap:NoncontrollingInterestMember 2018-01-01 2018-03-31 0000055785 kmb:BeforeTaxMember us-gaap:CostOfSalesMember kmb:AssetwriteoffsMember kmb:A2018GlobalRestructuringProgramMember 2019-01-01 2019-03-31 0000055785 kmb:AfterTaxMember kmb:A2018GlobalRestructuringProgramMember us-gaap:NoncontrollingInterestMember 2019-01-01 2019-03-31 0000055785 kmb:BeforeTaxMember kmb:A2018GlobalRestructuringProgramMember 2019-01-01 2019-03-31 0000055785 kmb:BeforeTaxMember us-gaap:CostOfSalesMember kmb:AssetwriteoffsMember kmb:A2018GlobalRestructuringProgramMember 2018-01-01 2018-03-31 0000055785 kmb:AfterTaxMember kmb:A2018GlobalRestructuringProgramMember us-gaap:ParentMember 2018-01-01 2018-03-31 0000055785 kmb:BeforeTaxMember kmb:A2018GlobalRestructuringProgramMember 2018-01-01 2018-03-31 0000055785 kmb:AfterTaxMember kmb:A2018GlobalRestructuringProgramMember 2019-01-01 2019-03-31 0000055785 kmb:AfterTaxMember kmb:A2018GlobalRestructuringProgramMember 2018-01-01 2018-03-31 0000055785 kmb:AfterTaxMember kmb:A2018GlobalRestructuringProgramMember us-gaap:ParentMember 2019-01-01 2019-03-31 0000055785 kmb:BeforeTaxMember us-gaap:OtherIncomeMember kmb:A2018GlobalRestructuringProgramMember 2019-01-01 2019-03-31 0000055785 kmb:U.S.TaxCutsandJobActMember 2018-01-01 2018-03-31 0000055785 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0000055785 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000055785 kmb:NetAssetValueorItsEquivalentMember us-gaap:FairValueMeasurementsRecurringMember 2019-03-31 0000055785 kmb:NetAssetValueorItsEquivalentMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0000055785 us-gaap:FairValueInputsLevel3Member 2019-03-31 0000055785 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0000055785 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-03-31 0000055785 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-03-31 0000055785 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-03-31 0000055785 us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-03-31 0000055785 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0000055785 us-gaap:FairValueInputsLevel1Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-31 0000055785 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-31 0000055785 us-gaap:FairValueInputsLevel3Member 2018-12-31 0000055785 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-03-31 0000055785 us-gaap:ParentMember 2019-01-01 2019-03-31 0000055785 us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0000055785 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000055785 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-03-31 0000055785 us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-03-31 0000055785 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-03-31 0000055785 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-03-31 0000055785 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-03-31 0000055785 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-03-31 0000055785 kmb:UnrealizedTranslationMember 2019-01-01 2019-03-31 0000055785 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-12-31 0000055785 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-12-31 0000055785 kmb:UnrealizedTranslationMember 2018-12-31 0000055785 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-03-31 0000055785 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-12-31 0000055785 kmb:UnrealizedTranslationMember 2018-01-01 2018-03-31 0000055785 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000055785 kmb:UnrealizedTranslationMember 2019-03-31 0000055785 kmb:UnrealizedTranslationMember 2018-03-31 0000055785 us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0000055785 kmb:UnrealizedTranslationMember 2017-12-31 0000055785 us-gaap:PensionPlansDefinedBenefitMember 2018-03-31 0000055785 us-gaap:PensionPlansDefinedBenefitMember 2019-03-31 0000055785 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-03-31 0000055785 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-12-31 0000055785 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-03-31 0000055785 us-gaap:ParentMember 2018-01-01 2018-03-31 0000055785 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-03-31 0000055785 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember 2019-03-31 0000055785 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2019-03-31 0000055785 us-gaap:NondesignatedMember 2018-01-01 2018-03-31 0000055785 us-gaap:InterestRateContractMember us-gaap:CashFlowHedgingMember 2019-03-31 0000055785 us-gaap:NetInvestmentHedgingMember 2019-03-31 0000055785 us-gaap:NondesignatedMember 2019-01-01 2019-03-31 0000055785 us-gaap:CashFlowHedgingMember 2019-01-01 2019-03-31 0000055785 us-gaap:FairValueHedgingMember 2018-01-01 2018-03-31 0000055785 kmb:AllOtherMember 2018-01-01 2018-03-31 0000055785 kmb:BabyandchildcareproductsMember 2018-01-01 2018-03-31 0000055785 kmb:KCProfessionalMember 2018-01-01 2018-03-31 0000055785 kmb:AllOtherMember 2019-01-01 2019-03-31 0000055785 kmb:ConsumerTissueMember 2019-01-01 2019-03-31 0000055785 kmb:BabyandchildcareproductsMember 2019-01-01 2019-03-31 0000055785 kmb:ConsumerTissueMember 2018-01-01 2018-03-31 0000055785 kmb:KCProfessionalMember 2019-01-01 2019-03-31 0000055785 kmb:BeforeTaxMember kmb:A2018GlobalRestructuringProgramMember kmb:ConsumerTissueMember 2019-01-01 2019-03-31 0000055785 kmb:BeforeTaxMember kmb:A2018GlobalRestructuringProgramMember kmb:PersonalCareMember 2019-01-01 2019-03-31 0000055785 kmb:BeforeTaxMember kmb:A2018GlobalRestructuringProgramMember kmb:KCProfessionalMember 2018-01-01 2018-03-31 0000055785 kmb:BeforeTaxMember kmb:A2018GlobalRestructuringProgramMember kmb:KCProfessionalMember 2019-01-01 2019-03-31 0000055785 kmb:BeforeTaxMember kmb:A2018GlobalRestructuringProgramMember kmb:ConsumerTissueMember 2018-01-01 2018-03-31 0000055785 kmb:BeforeTaxMember kmb:A2018GlobalRestructuringProgramMember kmb:PersonalCareMember 2018-01-01 2018-03-31 0000055785 kmb:PersonalCareMember 2019-01-01 2019-03-31 0000055785 kmb:ConsumerTissueMember 2019-01-01 2019-03-31 0000055785 kmb:KCProfessionalMember 2019-01-01 2019-03-31 0000055785 kmb:ConsumerTissueMember 2018-01-01 2018-03-31 0000055785 us-gaap:CorporateAndOtherMember 2019-01-01 2019-03-31 0000055785 kmb:PersonalCareMember 2018-01-01 2018-03-31 0000055785 us-gaap:CorporateAndOtherMember 2018-01-01 2018-03-31 0000055785 kmb:KCProfessionalMember 2018-01-01 2018-03-31 0000055785 kmb:OtherincomeandexpensenetMember 2019-01-01 2019-03-31 0000055785 kmb:OtherincomeandexpensenetMember 2018-01-01 2018-03-31 0000055785 kmb:LifoMember 2018-12-31 0000055785 kmb:NonLifoMember 2018-12-31 0000055785 kmb:LifoMember 2019-03-31 0000055785 kmb:NonLifoMember 2019-03-31 xbrli:pure iso4217:USD xbrli:shares iso4217:USD kmb:Employee xbrli:shares


 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 10-Q
 
(Mark One)
x    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2019
OR
o    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________ to ________  
Commission file number 1-225
 
http://api.tenkwizard.com/cgi/image?quest=1&rid=23&ipage=12846721&doc=12
KIMBERLY-CLARK CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware
 
39-0394230
(State or other jurisdiction of
incorporation)
 
(I.R.S. Employer
Identification No.)
P. O. Box 619100
Dallas, Texas
75261-9100
(Address of principal executive offices)
(Zip code)
(972) 281-1200
(Registrant's telephone number, including area code)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x    No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
x
  
Accelerated filer
o
Non-accelerated filer
o
  
Smaller reporting company
o
 
 
 
Emerging growth company
o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  o    No  x
As of April 15, 2019, there were 343,795,330 shares of the Corporation's common stock outstanding.
 



Table of Contents
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 




PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
CONSOLIDATED INCOME STATEMENT
(Unaudited)

 
 
Three Months Ended March 31
(Millions of dollars, except per share amounts)
 
2019
 
2018
Net Sales
 
$
4,633

 
$
4,731

Cost of products sold
 
3,205

 
3,407

Gross Profit
 
1,428

 
1,324

Marketing, research and general expenses
 
769

 
1,079

Other (income) and expense, net
 
4

 
(2
)
Operating Profit
 
655

 
247

Nonoperating expense
 
(11
)
 
(9
)
Interest income
 
3

 
2

Interest expense
 
(65
)
 
(66
)
Income Before Income Taxes and Equity Interests
 
582

 
174

Provision for income taxes
 
(143
)
 
(104
)
Income Before Equity Interests
 
439

 
70

Share of net income of equity companies
 
27

 
27

Net Income
 
466

 
97

Net income attributable to noncontrolling interests
 
(12
)
 
(4
)
Net Income Attributable to Kimberly-Clark Corporation
 
$
454

 
$
93

 
 
 
 
 
Per Share Basis
 
 
 
 
Net Income Attributable to Kimberly-Clark Corporation
 
 
 
 
Basic
 
$
1.32

 
$
0.27

Diluted
 
$
1.31

 
$
0.26

See notes to the unaudited interim consolidated financial statements.


1



KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
(Unaudited)

 
 
Three Months Ended March 31
(Millions of dollars)
 
2019
 
2018
Net Income
 
$
466

 
$
97

Other Comprehensive Income (Loss), Net of Tax
 
 
 
 
   Unrealized currency translation adjustments
 
26

 
117

   Employee postretirement benefits
 
(4
)
 

   Other
 
(17
)
 
(1
)
Total Other Comprehensive Income, Net of Tax
 
5

 
116

Comprehensive Income
 
471

 
213

   Comprehensive income attributable to noncontrolling interests
 
(7
)
 
(5
)
Comprehensive Income Attributable to Kimberly-Clark Corporation
 
$
464

 
$
208

See notes to the unaudited interim consolidated financial statements.


2



KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEET
(2019 Data is Unaudited)


(Millions of dollars)
 
March 31, 2019
 
December 31, 2018
ASSETS
 
 
 
 
Current Assets
 
 
 
 
Cash and cash equivalents
 
$
491

 
$
539

Accounts receivable, net
 
2,377

 
2,164

Inventories
 
1,857

 
1,813

Other current assets
 
530

 
525

Total Current Assets
 
5,255

 
5,041

Property, Plant and Equipment, Net
 
7,139

 
7,159

Investments in Equity Companies
 
246

 
224

Goodwill
 
1,476

 
1,474

Other Assets
 
1,088

 
620

TOTAL ASSETS
 
$
15,204

 
$
14,518

 
 
 
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY
 
 
 
 
Current Liabilities
 
 
 
 
Debt payable within one year
 
$
1,900

 
$
1,208

Trade accounts payable
 
3,027

 
3,190

Accrued expenses and other current liabilities
 
1,916

 
1,793

Dividends payable
 
354

 
345

Total Current Liabilities
 
7,197

 
6,536

Long-Term Debt
 
5,990

 
6,247

Noncurrent Employee Benefits
 
922

 
931

Deferred Income Taxes
 
496

 
458

Other Liabilities
 
617

 
328

Redeemable Preferred Securities of Subsidiaries
 
64

 
64

Stockholders' Equity
 
 
 
 
Kimberly-Clark Corporation
 
(305
)
 
(287
)
Noncontrolling Interests
 
223

 
241

Total Stockholders' Equity
 
(82
)
 
(46
)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY
 
$
15,204

 
$
14,518

See notes to the unaudited interim consolidated financial statements.


3



KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
CONSOLIDATED CASH FLOW STATEMENT
(Unaudited)
 
 
 
Three Months Ended March 31
(Millions of dollars)
 
2019
 
2018
Operating Activities
 
 
 
 
Net income
 
$
466

 
$
97

Depreciation and amortization
 
234

 
211

Asset impairments
 

 
74

Stock-based compensation
 
16

 
18

Deferred income taxes
 
11

 
(27
)
Net losses on asset dispositions
 
6

 
36

Equity companies' earnings in excess of dividends paid
 
(27
)
 
(27
)
Operating working capital
 
(375
)
 
103

Postretirement benefits
 
(12
)
 
(41
)
Other
 
(2
)
 
98

Cash Provided by Operations
 
317

 
542

Investing Activities
 
 
 
 
Capital spending
 
(316
)
 
(189
)
Investments in time deposits
 
(80
)
 
(83
)
Maturities of time deposits
 
72

 
19

Other
 

 
(3
)
Cash Used for Investing
 
(324
)
 
(256
)
Financing Activities
 
 
 
 
Cash dividends paid
 
(345
)
 
(341
)
Change in short-term debt
 
851

 
249

Debt repayments
 
(402
)
 
(2
)
Proceeds from exercise of stock options
 
26

 
14

Acquisitions of common stock for the treasury
 
(164
)
 
(197
)
Other
 
(8
)
 
(6
)
Cash Used for Financing
 
(42
)
 
(283
)
Effect of Exchange Rate Changes on Cash and Cash Equivalents
 
1

 
7

Change in Cash and Cash Equivalents
 
(48
)
 
10

Cash and Cash Equivalents - Beginning of Period
 
539

 
616

Cash and Cash Equivalents - End of Period
 
$
491

 
$
626

See notes to the unaudited interim consolidated financial statements.


4



KIMBERLY-CLARK CORPORATION AND SUBSIDIARIES
NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1. Accounting Policies
Basis of Presentation
The accompanying unaudited interim consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all material adjustments which are of a normal and recurring nature necessary for a fair presentation of the results for the periods presented have been reflected. Dollar amounts are reported in millions, except per share dollar amounts, unless otherwise noted.
For further information, refer to the consolidated financial statements and footnotes included in our Annual Report on Form 10‑K for the year ended December 31, 2018. The terms "Corporation," "Kimberly-Clark," "K-C," "we," "our" and "us" refer to Kimberly-Clark Corporation and its consolidated subsidiaries.
Highly Inflationary Accounting in Argentina
GAAP guidance requires the use of highly inflationary accounting for countries whose cumulative three-year inflation exceeds 100 percent. In the second quarter of 2018, published inflation indices indicated that the three-year cumulative inflation in Argentina exceeded 100 percent, and as of July 1, 2018, we elected to adopt highly inflationary accounting for our subsidiaries in Argentina (“K-C Argentina”). Under highly inflationary accounting, K-C Argentina’s functional currency became the U.S. dollar, and its income statement and balance sheet have been measured in U.S. dollars using both current and historical rates of exchange. The effect of changes in exchange rates on peso-denominated monetary assets and liabilities has been reflected in earnings in Other (income) and expense, net and was not material.  As of March 31, 2019, K-C Argentina had a small net peso monetary position. Net sales of K-C Argentina were less than 2 percent of our consolidated net sales for the three months ended March 31, 2019 and 2018.
Leases
Lease assets and lease liabilities are recognized at the commencement of an arrangement where it is determined at inception that a lease exists.  Lease assets represent the right to use an underlying asset for the lease term, and lease liabilities represent the obligation to make lease payments arising from the lease.  These assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our incremental borrowing rate generally applicable to the location of the lease asset, unless the implicit rate is readily determinable.  Lease assets also include any upfront lease payments made and exclude lease incentives.  Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised.
Variable lease payments are generally expensed as incurred and include certain index-based changes in rent, certain nonlease components, such as maintenance and other services provided by the lessor, and other charges included in the lease.  Leases with an initial term of 12 months or less are not recorded on the balance sheet, and the expense for these short-term leases and for operating leases is recognized on a straight-line basis over the lease term.
Lease agreements with lease and nonlease components are combined as a single lease component.  The depreciable life of lease assets and leasehold improvements is limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise.
Recently Adopted Accounting Standards
The Financial Accounting Standards Board (the "FASB") issued Accounting Standards Update ("ASU") No. 2016-02, Leases (Topic 842), amended by ASU 2018-11, Leases (Topic 842): Targeted Improvements. The new guidance requires a lessee to recognize assets and liabilities for all leases with lease terms of more than 12 months and provide additional disclosures. The ASU requires adoption using a modified retrospective transition approach with either 1) periods prior to the adoption date being recast or 2) a cumulative-effect adjustment recognized to the opening balance of retained earnings on the adoption date with prior periods not recast.  We adopted this standard on January 1, 2019 using the cumulative-effect adjustment approach. We elected the package of practical expedients in transition for leases that commenced prior to January 1, 2019 whereby these contracts were not reassessed or reclassified from their previous assessment as of December 31, 2018. We also elected certain other practical expedients in transition including not reassessing existing land easements as lease contracts. For all new and modified leases after adoption of the ASU, we have taken the component election allowing us to account for lease components together with non lease components in the calculation of the lease asset and corresponding liability. We implemented processes and a lease accounting system to ensure adequate internal controls were in place to assess our contracts and enable proper accounting and reporting of

5



financial information upon adoption.  No cumulative-effect adjustment was recognized as the amount was not material, and the impact on our results of operations and cash flows was also not material. See Note 7 for the financial position impact and additional disclosures.
The FASB issued ASU No. 2017-12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities. The new standard makes more financial and non-financial hedging strategies eligible for hedge accounting. It also amends presentation and disclosure requirements and changes how companies assess hedge effectiveness. This ASU requires adoption using a modified retrospective transition approach with a cumulative-effect adjustment recognized to the opening balance of retained earnings on the adoption date with prior periods not recast. We adopted this standard on January 1, 2019 with no cumulative-effect adjustment as the amount was not material. The effects of this standard on our financial position, results of operations and cash flows were not material.
Accounting Standards Issued - Not Yet Adopted
The FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820).  The new guidance modifies disclosure requirements related to fair value measurement.  The amendments in this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019.  Implementation on a prospective or retrospective basis varies by specific disclosure requirement.  Early adoption is permitted. The standard also allows for early adoption of any removed or modified disclosures upon issuance of this ASU while delaying adoption of the additional disclosures until their effective date.
The FASB issued ASU No. 2018-15, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40).  The new guidance reduces complexity for the accounting for costs of implementing a cloud computing service arrangement and aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license).  For public companies, the amendments in this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019, with early adoption permitted.  Implementation should be applied either retrospectively or prospectively to all implementation costs incurred after the date of adoption.  The effects of this standard on our financial position, results of operations or cash flows are not expected to be material.
Note 2.    2018 Global Restructuring Program
In January 2018, we announced the 2018 Global Restructuring Program to reduce our structural cost base by streamlining and simplifying our manufacturing supply chain and overhead organization. We expect to close or sell approximately 10 manufacturing facilities and expand production capacity at several others. We expect to exit or divest some lower-margin businesses that generate approximately 1 percent of our net sales. The sales are concentrated in our consumer tissue business segment. The restructuring is expected to impact our organizations in all major geographies. Workforce reductions are expected to be in the range of 5,000 to 5,500. Certain capital appropriations under the 2018 Global Restructuring Program are being finalized. Accounting for actions related to each appropriation will commence when the appropriation is authorized for execution.
The restructuring is expected to be completed by the end of 2020, with total costs anticipated to be $1.7 billion to $1.9 billion pre-tax ($1.35 billion to $1.5 billion after tax). Cash costs are expected to be $900 to $1.0 billion, primarily related to workforce reductions.  Non-cash charges are expected to be $800 to $900 pre-tax and will primarily consist of incremental depreciation, asset write-offs and pension settlement and curtailment charges. Restructuring charges in 2019 are expected to be $600 to $750 pre-tax ($470 to $570 after tax).

6



The following charges were incurred in connection with the 2018 Global Restructuring Program:
 
Three Months Ended
March 31, 2019
 
Three Months Ended
March 31, 2018
Cost of products sold:
 
 
 
Charges for workforce reductions
$
30

 
$
119

Asset impairments

 
74

Asset write-offs
12

 
55

Incremental depreciation
67

 
28

Other exit costs
16

 
1

Total
125

 
277

Marketing, research and general expenses:
 
 
 
Charges for workforce reductions
4

 
286

Other exit costs
24

 
14

Total
28

 
300

Other (income) and expense, net
(1
)
 

Total charges
152

 
577

Provision for income taxes
(31
)
 
(143
)
Net charges
121

 
434

Net impact related to equity companies and noncontrolling interests
1

 
(6
)
Net charges attributable to Kimberly-Clark Corporation
$
122

 
$
428


The asset impairment charges were measured based on the excess of the carrying value of the impacted asset groups over their fair values. These fair values were measured by using discounted cash flows expected over the limited time the assets would remain in use and as a result, the assets were essentially written off. The use of discounted cash flows represents a level 3 measure under the fair value hierarchy.
The following summarizes the 2019 restructuring liabilities activity:
 
 
2019
 
2018
Restructuring liabilities at January 1
 
$
210

 
$

Charges for workforce reductions and other cash exit costs
 
74

 
418

Cash payments
 
(71
)
 
(14
)
Currency and other
 
6

 
3

Restructuring liabilities at March 31
 
$
219

 
$
407


Restructuring liabilities of $132 and $306 are recorded in Accrued expenses and other current liabilities and $87 and $101 are recorded in Other Liabilities as of March 31, 2019 and 2018, respectively. The impact related to restructuring charges is recorded in Operating working capital and Other Operating Activities, as appropriate, in our consolidated cash flow statement.
Through March 31, 2019, cumulative pre-tax charges for the 2018 Global Restructuring Program were $1.2 billion ($905 after tax).
Note 3. U.S. Tax Reform
On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the "Tax Act"). In the period ended December 31, 2017, we recorded a provisional discrete net tax benefit related to the transition tax, remeasurement of deferred taxes, our reassessment of permanently reinvested earnings, uncertain tax positions and valuation allowances, and actions taken in anticipation of the Tax Act. The provisional amounts recorded in 2017 were finalized in 2018.  During 2018, we recorded discrete net tax expense related to new guidance issued during 2018 affecting tax benefits we recorded in the period ended December 31, 2017 for the transition tax and certain tax planning actions taken in anticipation of the Tax Act.  At December 31, 2018, we finalized our policy and elected to use the period cost method for global intangible low-taxed income (“GILTI”) provisions and therefore have not recorded deferred taxes for basis differences expected to reverse in future periods.

7



In the first quarter of 2018, we recorded discrete net tax expense of $82 primarily related to guidance issued affecting tax benefits we recorded in the fourth quarter of 2017 for certain tax planning actions taken in anticipation of the Tax Act. 
Note 4. Fair Value Information
The following fair value information is based on a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The three levels in the hierarchy used to measure fair value are:
Level 1 – Unadjusted quoted prices in active markets accessible at the reporting date for identical assets and liabilities.
Level 2 – Quoted prices for similar assets or liabilities in active markets. Quoted prices for identical or similar assets and liabilities in markets that are not considered active or financial instruments for which all significant inputs are observable, either directly or indirectly.
Level 3 – Prices or valuations that require inputs that are significant to the valuation and are unobservable.
A financial instrument's level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.
During the three months ended March 31, 2019 and for the full year 2018, there were no significant transfers among level 1, 2, or 3 fair value determinations.
Derivative assets and liabilities are measured on a recurring basis at fair value. At March 31, 2019 and December 31, 2018, derivative assets were $29 and $30, respectively, and derivative liabilities were $29 and $18, respectively. The fair values of derivatives used to manage interest rate risk and commodity price risk are based on LIBOR rates and interest rate swap curves and NYMEX price quotations, respectively. The fair values of hedging instruments used to manage foreign currency risk are based on published quotations of spot currency rates and forward points, which are converted into implied forward currency rates. Measurement of our derivative assets and liabilities is considered a level 2 measurement. Additional information on our classification and use of derivative instruments is contained in Note 8.
Redeemable preferred securities of subsidiaries are measured on a recurring basis at fair value and were $64 at both March 31, 2019 and December 31, 2018. They are not traded in active markets. For certain redeemable securities, fair values were calculated using a floating rate pricing model that compared the stated spread to the fair value spread to determine the price at which each of the financial instruments should trade. The model used the following inputs to calculate fair values: face value, current LIBOR rate, unobservable fair value credit spread, stated spread, maturity date and interest or dividend payment dates. The fair values of the remaining redeemable securities were based on a discounted cash flow valuation model. Measurement of the redeemable preferred securities is considered a level 3 measurement.
Company-owned life insurance ("COLI") assets are measured on a recurring basis at fair value. COLI assets were $69 and $64 at March 31, 2019 and December 31, 2018, respectively. The COLI policies are a source of funding primarily for our nonqualified employee benefits and are included in other assets. The COLI policies are measured at fair value using the net asset value per share practical expedient, and therefore, are not classified in the fair value hierarchy.

8



The following table includes the fair value of our financial instruments for which disclosure of fair value is required:
 
Fair Value Hierarchy Level
 
Carrying Amount
 
Estimated Fair Value
 
Carrying Amount
 
Estimated Fair Value
 
 
March 31, 2019
 
December 31, 2018
Assets
 
 
 
 
 
 
 
 
 
Cash and cash equivalents(a)
1
 
$
491

 
$
491

 
$
539

 
$
539

Time deposits(b)
1
 
260

 
260

 
256

 
256

Liabilities and redeemable securities of subsidiaries
 
 
 
 
 
 
 
 
 
Short-term debt(c)
2
 
1,338

 
1,338

 
495

 
495

Long-term debt(d)
2
 
6,552

 
7,017

 
6,960

 
7,192

(a)
Cash equivalents are composed of certificates of deposit, time deposits and other interest-bearing investments with original maturity dates of 90 days or less. Cash equivalents are recorded at cost, which approximates fair value.
(b)
Time deposits are composed of deposits with original maturities of more than 90 days but less than one year and instruments with original maturities of greater than one year, included in other current assets or other assets in the consolidated balance sheet, as appropriate. Time deposits are recorded at cost, which approximates fair value.
(c)
Short-term debt is composed of U.S. commercial paper and/or other similar short-term debt issued by non-U.S. subsidiaries, all of which are recorded at cost, which approximates fair value.
(d)
Long-term debt includes the current portion of these debt instruments. Fair values were estimated based on quoted prices for financial instruments for which all significant inputs were observable, either directly or indirectly.
Note 5. Earnings Per Share ("EPS")
There are no adjustments required to be made to net income for purposes of computing EPS. The average number of common shares outstanding is reconciled to those used in the basic and diluted EPS computations as follows:
 
 
Three Months Ended March 31
(Millions of shares)
 
2019
 
2018
Basic
 
344.3

 
350.4

Dilutive effect of stock options and restricted share unit awards
 
1.7

 
2.2

Diluted
 
346.0

 
352.6


The impact of options outstanding that were not included in the computation of diluted EPS because their exercise price was greater than the average market price of the common shares was insignificant. The number of common shares outstanding as of March 31, 2019 and 2018 was 343.9 million and 349.6 million, respectively.
Note 6. Stockholders' Equity
Set forth below is a reconciliation for the three months ended March 31, 2019 and 2018 of the carrying amount of total stockholders' equity from the beginning of the period to the end of the period.
 
 
Stockholders' Equity Attributable to
 
 
The Corporation
 
Noncontrolling Interests
Balance at December 31, 2018
 
$
(287
)
 
$
241

Net Income
 
454

 
11

Other comprehensive income, net of tax
 
10

 
(5
)
Stock-based awards exercised or vested
 
28

 

Recognition of stock-based compensation
 
17

 

Shares repurchased
 
(174
)
 

Dividends declared ($1.03 per share)
 
(354
)
 
(24
)
Other
 
1

 

Balance at March 31, 2019
 
$
(305
)
 
$
223



9



 
 
Stockholders' Equity Attributable to
 
 
The Corporation
 
Noncontrolling Interests
Balance at December 31, 2017
 
$
629

 
$
253

Net Income
 
93

 
3

Other comprehensive income, net of tax
 
115

 
1

Stock-based awards exercised or vested
 
14

 

Recognition of stock-based compensation
 
17

 

Shares repurchased
 
(211
)
 

Dividends declared ($1.00 per share)
 
(350
)
 
(20
)
Other
 
10

 
1

Balance at March 31, 2018
 
$
317

 
$
238


During the three months ended March 31, 2019, we repurchased 1.4 million shares at a total cost of $167 pursuant to a share repurchase program authorized by our Board of Directors.
Net unrealized currency gains or losses resulting from the translation of assets and liabilities of foreign subsidiaries, except those in highly inflationary economies, are recorded in Accumulated Other Comprehensive Income ("AOCI"). For these operations, changes in exchange rates generally do not affect cash flows; therefore, unrealized translation adjustments are recorded in AOCI rather than net income. Upon sale or substantially complete liquidation of any of these subsidiaries, the applicable unrealized translation would be removed from AOCI and reported as part of the gain or loss on the sale or liquidation.
Also included in unrealized translation amounts are the effects of foreign exchange rate changes on intercompany balances of a long-term investment nature and transactions designated as hedges of net foreign investments.
The change in net unrealized currency translation for the three months ended March 31, 2019 was primarily due to strengthening of foreign currencies versus the U.S. dollar.
The changes in the components of AOCI attributable to Kimberly-Clark, net of tax, are as follows:
 
 
Unrealized Translation
 
Defined Benefit Pension Plans
 
Other Postretirement Benefit Plans
 
Cash Flow Hedges and Other
Balance as of December 31, 2017
 
$
(1,864
)
 
$
(976
)
 
$
(39
)
 
$
(40
)
Other comprehensive income (loss) before reclassifications
 
116

 
(10
)
 

 
(9
)
Loss reclassified from AOCI
 

 
10

(a)

 
8

Net current period other comprehensive income (loss)
 
116

 

 

 
(1
)
Balance as of March 31, 2018
 
$
(1,748
)
 
$
(976
)
 
$
(39
)
 
$
(41
)
 
 
 
 
 
 
 
 
 
Balance as of December 31, 2018
 
$
(2,297
)
 
$
(1,017
)
 
$
12

 
$
3

Other comprehensive income (loss) before reclassifications
 
31

 
(7
)
 

 
(12
)
(Income) loss reclassified from AOCI
 

 
3

(a)

 
(5
)
Net current period other comprehensive income (loss)
 
31

 
(4
)
 

 
(17
)
Balance as of March 31, 2019
 
$
(2,266
)
 
$
(1,021
)
 
$
12

 
$
(14
)

(a)
Included in computation of net periodic benefit costs.
Note 7. Leases
We have entered into leases for certain facilities, vehicles, material handling and other equipment. Our leases have remaining contractual terms up to 20 years, some of which include options to extend the leases for up to 20 years, and some of which include options to terminate the leases within 1 year. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants. Our operating lease costs are primarily related to facility leases for inventory warehousing and administration offices, and our finance leases are immaterial.

10



Operating Lease Cost
 
 
Three Months Ended
March 31, 2019
 
Income Statement Classification
Lease cost
 
$
39

 
Cost of products sold, Marketing, research and general expenses
Variable lease cost(a)
 
37

 
Cost of products sold, Marketing, research and general expenses
Total lease cost
 
$
76

 
 
(a)    Includes short-term leases, which are immaterial.
Operating Lease Assets and Liabilities
 
 
March 31, 2019
 
Balance Sheet Classification
Lease assets
 
$
421

 
Other Assets
 
 
 
 
 
Current lease liabilities
 
$
131

 
Accrued expenses and other current liabilities
Noncurrent lease liabilities
 
301

 
Other Liabilities
Total lease liabilities
 
$
432

 
 

Maturity of Operating Lease Liabilities
 
 
March 31, 2019
2019
 
$
114

2020
 
124

2021
 
86

2022
 
58

2023
 
40

Thereafter
 
73

Total lease payments
 
495

Less imputed interest
 
63

Present value of lease liabilities
 
$
432


As of March 31, 2019, our operating leases have a weighted-average remaining lease term of 4.6 years and a weighted-average discount rate of 5.2 percent. Cash paid for amounts included in the measurement of operating lease liabilities was $39 for the three months ended March 31, 2019.
The future minimum obligations under operating leases in effect as of December 31, 2018 having a noncancelable term in excess of one year as determined prior to the adoption of ASU 842 are as follows:
 
 
December 31, 2018
2019
 
$
160

2020
 
123

2021
 
85

2022
 
57

2023
 
41

Thereafter
 
72

Future minimum obligations
 
$
538


Note 8. Objectives and Strategies for Using Derivatives
As a multinational enterprise, we are exposed to financial risks, such as changes in foreign currency exchange rates, interest rates, and commodity prices. We employ a number of practices to manage these risks, including operating and financing activities and, where appropriate, the use of derivative instruments. We enter into derivative instruments to hedge a portion of forecasted cash flows denominated in foreign currencies for non-U.S. operations' purchases of raw materials, which are priced in U.S. dollars, and imports of intercompany finished goods and work-in-process priced predominantly in U.S. dollars and euros. The derivative instruments used to manage these exposures are designated and qualify as cash flow hedges. The foreign currency exposure on

11



certain non-functional currency denominated monetary assets and liabilities, primarily intercompany loans and accounts payable, is hedged with primarily undesignated derivative instruments.
Interest rate risk is managed using a portfolio of variable and fixed-rate debt composed of short and long-term instruments. Interest rate swap contracts may be used to facilitate the maintenance of the desired ratio of variable and fixed-rate debt and are designated and qualify as fair value hedges. From time to time, we also hedge the anticipated issuance of fixed-rate debt, and these contracts are designated as cash flow hedges.
We use derivative instruments, such as forward swap contracts, to hedge a limited portion of our exposure to market risk arising from changes in prices of certain commodities. These derivatives are designated as cash flow hedges of specific quantities of the underlying commodity expected to be purchased in future months.
Translation adjustments result from translating foreign entities' financial statements into U.S. dollars from their functional currencies. The risk to any particular entity's net assets is reduced to the extent that the entity is financed with local currency borrowings. A portion of our balance sheet translation exposure for certain affiliates, which results from changes in translation rates between the affiliates’ functional currencies and the U.S. dollar, is hedged with financial instruments. These instruments are designated as net investment hedges and have an aggregate notional value of $1.1 billion at March 31, 2019. Changes in fair value of net investment hedges are recorded in AOCI as part of the cumulative translation adjustment. For the three months ended March 31, 2019, $12 of unrealized gains related to net investment hedge fair value changes were recorded in AOCI and no significant amounts were reclassified from AOCI to Interest expense.
At March 31, 2019 and December 31, 2018, derivative assets were $29 and $30, respectively, and derivative liabilities were $29 and $18, respectively, primarily comprised of foreign currency exchange contracts. Derivative assets are recorded in Other current assets or Other Assets, as appropriate, and derivative liabilities are recorded in Accrued expenses and other current liabilities or Other Liabilities, as appropriate.
Derivative instruments that are designated and qualify as fair value hedges are predominantly used to manage interest rate risk. The fair values of these interest rate derivative instruments are recorded as an asset or liability, as appropriate, with the offset recorded in Interest expense. The offset to the change in fair values of the related debt is also recorded in Interest expense. Any realized gain or loss on the derivatives that hedge interest rate risk is amortized to Interest expense over the life of the related debt. As of March 31, 2019, the aggregate notional values and carrying values of outstanding interest rate contracts designated as fair value hedges were $300 and $299, respectively. For the three months ended March 31, 2019 and 2018, gains or losses recognized in Interest expense for interest rate swaps were not significant. The cumulative changes in fair value of related hedged items for which hedge accounting has been discontinued were not significant as of March 31, 2019.
For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative instrument is initially recorded in AOCI, net of related income taxes, and recognized in earnings in the same income statement line and period that the hedged exposure affects earnings. As of March 31, 2019, outstanding commodity forward contracts were in place to hedge a limited portion of our estimated requirements of the related underlying commodities in the remainder of 2019 and future periods. As of March 31, 2019, the aggregate notional values of outstanding foreign exchange and interest rate derivative contracts designated as cash flow hedges were $625 and $100, respectively. For the three months ended March 31, 2019 and 2018, no significant gains or losses were reclassified into Interest expense, Cost of products sold or Other (income) and expense, net as a result of the discontinuance of cash flow hedges due to the original forecasted transaction no longer being probable of occurring. At March 31, 2019, amounts to be reclassified from AOCI into Interest expense, Cost of products sold or Other (income) and expense, net during the next twelve months are not expected to be material. The maximum maturity of cash flow hedges in place at March 31, 2019 is March 2021.
No significant amounts were excluded from the assessment of net investment, fair value or cash flow hedge effectiveness as of March 31, 2019.
Gains or losses on undesignated foreign exchange hedging instruments are immediately recognized in Other (income) and expense, net. Losses of $8 and $3 were recorded in the three months ended March 31, 2019 and 2018, respectively. The effect on earnings from the use of these non-designated derivatives is substantially neutralized by the transactional gains and losses recorded on the underlying assets and liabilities. At March 31, 2019, the notional value of these undesignated derivative instruments was approximately $1.7 billion.

12



Note 9. Business Segment Information
We are organized into operating segments based on product groupings. These operating segments have been aggregated into three reportable global business segments: Personal Care, Consumer Tissue and K-C Professional. The reportable segments were determined in accordance with how our chief operating decision maker and our executive managers develop and execute global strategies to drive growth and profitability. These strategies include global plans for branding and product positioning, technology, research and development programs, cost reductions including supply chain management, and capacity and capital investments for each of these businesses. Segment management is evaluated on several factors, including operating profit. Segment operating profit excludes Other (income) and expense, net and income and expense not associated with ongoing operations of the business segments, including the costs of corporate decisions related to the 2018 Global Restructuring Program described in Note 2.
The principal sources of revenue in each global business segment are described below:
Personal Care brands offer our consumers a trusted partner in caring for themselves and their families by delivering confidence, protection and discretion through a wide variety of innovative solutions and products such as disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, and other related products. Products in this segment are sold under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Kotex, U by Kotex, Intimus, Depend, Plenitud, Poise and other brand names.
Consumer Tissue offers a wide variety of innovative solutions and trusted brands that responsibly improve everyday living for families around the world. Products in this segment include facial and bathroom tissue, paper towels, napkins and related products, and are sold under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve and other brand names.
K-C Professional partners with businesses to create Exceptional Workplaces, helping to make them healthier, safer and more productive through a range of solutions and supporting products such as wipers, tissue, towels, apparel, soaps and sanitizers. Our brands, including Kleenex, Scott, WypAll, Kimtech and KleenGuard are well known for quality and trusted to help people around the world work better.
Information concerning consolidated operations by business segment is presented in the following tables:
 
 
Three Months Ended March 31
 
 
 
 
2019
 
2018
 
Change
NET SALES
 
 
 
 
 
 
Personal Care
 
$
2,275

 
$
2,307

 
-1
 %
Consumer Tissue
 
1,526

 
1,579

 
-3
 %
K-C Professional
 
817

 
832

 
-2
 %
Corporate & Other
 
15

 
13

 
N.M.

TOTAL NET SALES
 
$
4,633

 
$
4,731

 
-2
 %
 
 
 
 
 
 
 
OPERATING PROFIT
 
 
 
 
 
 
Personal Care
 
$
484

 
$
470

 
+3
 %
Consumer Tissue
 
241

 
249

 
-3
 %
K-C Professional
 
150

 
158

 
-5
 %
Corporate & Other(a)
 
(216
)
 
(632
)
 
N.M.

Other (income) and expense, net(a)
 
4

 
(2
)
 
N.M.

TOTAL OPERATING PROFIT
 
$
655

 
$
247

 
+165
 %
(a)
Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including charges related to the 2018 Global Restructuring Program. Restructuring charges related to the personal care, consumer tissue and K-C Professional business segments were $89, $46 and $16, respectively, for the three months ended March 31, 2019, and $314, $141 and $95, respectively, for the three months ended March 31, 2018.
N.M. - Not Meaningful

13



Sales of Principal Products
 
 
Three Months Ended March 31
(Billions of dollars)
 
2019
 
2018
Consumer tissue products
 
$
1.5

 
$
1.6

Baby and child care products
 
1.6

 
1.6

Away-from-home professional products
 
0.8

 
0.8

All other
 
0.7

 
0.7

Consolidated
 
$
4.6

 
$
4.7

Note 10. Supplemental Balance Sheet Data
The following schedule presents a summary of inventories by major class:
 
 
March 31, 2019
 
December 31, 2018
 
 
LIFO
 
Non-LIFO
 
Total
 
LIFO
 
Non-LIFO
 
Total
Raw materials
 
$
96

 
$
248

 
$
344

 
$
99

 
$
263

 
$
362

Work in process
 
119

 
93

 
212

 
120

 
94

 
214

Finished goods
 
494

 
725

 
1,219

 
461

 
692

 
1,153

Supplies and other
 

 
278

 
278

 

 
275

 
275

 
 
709

 
1,344

 
2,053

 
680

 
1,324

 
2,004

Excess of FIFO or weighted-average cost over LIFO cost
 
(196
)
 

 
(196
)
 
(191
)
 

 
(191
)
Total
 
$
513

 
$
1,344

 
$
1,857

 
$
489

 
$
1,324

 
$
1,813


Inventories are valued at the lower of cost or net realizable value, determined on the FIFO or weighted-average cost methods, and at the lower of cost or market, determined on the LIFO cost method.
The following schedule presents a summary of property, plant and equipment, net:
 
March 31, 2019
 
December 31, 2018
Land
$
168

 
$
169

Buildings
2,814

 
2,787

Machinery and equipment
14,194

 
14,059

Construction in progress
648

 
699

 
17,824

 
17,714

Less accumulated depreciation
(10,685
)
 
(10,555
)
Total
$
7,139

 
$
7,159



14



Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Introduction
This management's discussion and analysis ("MD&A") of financial condition and results of operations is intended to provide investors with an understanding of our recent performance, financial condition and prospects.  The following will be discussed and analyzed:
Overview of First Quarter 2019 Results
Results of Operations and Related Information
Liquidity and Capital Resources
Business Outlook
Information Concerning Forward-Looking Statements
We describe our business outside North America in two groups – Developing and Emerging Markets ("D&E") and Developed Markets. D&E markets comprise Eastern Europe, the Middle East and Africa, Latin America and Asia-Pacific, excluding Australia and South Korea. Developed Markets consist of Western and Central Europe, Australia and South Korea.
This section presents a discussion and analysis of our first quarter 2019 net sales, operating profit and other information relevant to an understanding of the results of operations. In addition, we provide commentary regarding organic sales growth, which describes the impact of changes in volume, net selling prices and product mix on net sales. Change in foreign currency exchange rates and exited businesses also impact the year-over-year change in net sales. Our analysis compares the three months ended March 31, 2019 results to the same period in 2018.
Throughout this MD&A, we refer to financial measures that have not been calculated in accordance with accounting principles generally accepted in the U.S., or GAAP, and are therefore referred to as non-GAAP financial measures. These measures include adjusted gross and operating profit, adjusted net income, adjusted earnings per share, adjusted other (income) and expense, net and adjusted effective tax rate. We believe these measures provide our investors with additional information about our underlying results and trends, as well as insight into some of the financial measures used to evaluate management.
Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP measures, and they should be read only in conjunction with our unaudited interim consolidated financial statements prepared in accordance with GAAP.  There are limitations to these non-GAAP financial measures because they are not prepared in accordance with GAAP and may not be comparable to similarly titled measures of other companies due to potential differences in methods of calculation and items being excluded.  We compensate for these limitations by using these non-GAAP financial measures as a supplement to the GAAP measures and by providing reconciliations of the non-GAAP and comparable GAAP financial measures.
The non-GAAP financial measures exclude the following items for the relevant time periods as indicated in the reconciliations included later in this MD&A:
2018 Global Restructuring Program - In 2018, we initiated this restructuring program to reduce our structural cost base by streamlining and simplifying our manufacturing supply chain and overhead organization. See Note 2 to the unaudited interim consolidated financial statements for details.
U.S. Tax Reform Related Matters - In 2018, we recognized net charges associated with U.S. tax reform related matters. See Note 3 to the unaudited interim consolidated financial statements for details.
Overview of First Quarter 2019 Results
Net sales of $4.6 billion decreased 2 percent compared to the year-ago period. Changes in foreign currency exchange rates reduced sales by 5 percent, while organic sales increased 3 percent including higher net selling prices of 4 percent.
Operating profit was $655 in 2019 and $247 in 2018. Net Income Attributable to Kimberly-Clark Corporation was $454 in 2019 compared to $93 in 2018, and diluted earnings per share were $1.31 in 2019 compared to $0.26 in 2018. Results in 2019 and 2018 include charges related to the 2018 Global Restructuring Program. Results in 2018 also include a net charge associated with U.S. tax reform related matters.
Results of Operations and Related Information
This section presents a discussion and analysis of our first quarter 2019 net sales, operating profit and other information relevant to an understanding of the results of operations.

15



Consolidated
Selected Financial Results
Three Months Ended March 31
 
2019
 
2018
 
Percent Change
Net Sales:
 
 
 
 

North America
$
2,390

 
$
2,385

 
 %
Outside North America
2,315

 
2,422

 
-4
 %
Intergeographic sales
(72
)
 
(76
)
 
N.M.

Total Net Sales
4,633

 
4,731

 
-2
 %
Operating Profit:
 
 
 
 
 
North America
572

 
553

 
3
 %
Outside North America
303

 
324

 
-6
 %
Corporate & Other(a)
(216
)
 
(632
)
 
N.M.

Other (income) and expense, net(a)
4

 
(2
)
 
N.M.

Total Operating Profit
655

 
247

 
+165
 %
Share of net income of equity companies
27

 
27

 
 %
Net Income Attributable to Kimberly-Clark Corporation
454

 
93

 
+388
 %
Diluted Earnings per Share
1.31

 
0.26

 
+404
 %
(a)
Corporate & Other and Other (income) and expense, net include income and expense not associated with the business segments, including adjustments as indicated in the Non-GAAP Reconciliations.
N.M. - Not Meaningful
GAAP to Non-GAAP Reconciliations of Selected Financial Results
 
 
Three Months Ended March 31, 2019
 
 
As
Reported
 
2018 Global
Restructuring
Program
 
As
Adjusted
Non-GAAP
Cost of products sold
 
$
3,205

 
$
125

 
$
3,080

Gross Profit
 
1,428

 
(125
)
 
1,553

Marketing, research and general expenses
 
769

 
28

 
741

Other (income) and expense, net
 
4

 
(1
)
 
5

Operating Profit
 
655

 
(152
)
 
807

Provision for income taxes
 
(143
)
 
31

 
(174
)
Effective tax rate
 
24.6
%
 

 
23.7
%
Share of net income of equity companies
 
27

 
(2
)
 
29

Net income attributable to noncontrolling interests
 
(12
)
 
1

 
(13
)
Net Income Attributable to Kimberly-Clark Corporation
 
454

 
(122
)
 
576

Diluted Earnings per Share
 
1.31

 
(0.35
)
 
1.66


16





 
Three Months Ended March 31, 2018
 
 
As
Reported
 
2018 Global Restructuring Program
 
U.S. Tax Reform Related Matters
 
As
Adjusted
Non-GAAP
Cost of products sold
 
$
3,407

 
$
277

 
$

 
$
3,130

Gross Profit
 
1,324

 
(277
)
 

 
1,601

Marketing, research and general expenses
 
1,079

 
300

 

 
779

Operating Profit
 
247

 
(577
)
 

 
824

Provision for income taxes
 
(104
)
 
143

 
(82
)
 
(165
)
Effective tax rate
 
59.8
%
 

 

 
22.0
%
Share of net income of equity companies
 
27

 
(3
)
 

 
30

Net income attributable to noncontrolling interests
 
(4
)
 
9

 

 
(13
)
Net Income Attributable to Kimberly-Clark Corporation
 
93

 
(428
)
 
(82
)
 
603

Diluted Earnings per Share(a)
 
0.26

 
(1.21
)
 
(0.23
)
 
1.71

(a) "As Adjusted Non-GAAP" may not equal "As Reported" plus "Adjustments" as a result of rounding.
Analysis of Consolidated Results
Net Sales
 
Percent Change For the Three Months Ended
March 31, 2019
 
Adjusted Operating Profit
 
Percent Change For the Three Months Ended
March 31, 2019
Volume
 
(2
)
 
Volume
 
(2
)
Net Price
 
4

 
Net Price
 
20

Mix/Other
 
1

 
Input Costs
 
(16
)
Currency
 
(5
)
 
Cost Savings(c)
 
14

Total(a)
 
(2
)
 
Currency Translation
 
(3
)
 
 
 
 
Other(d)
 
(15
)
Organic(b)
 
3

 
Total
 
(2
)
(a) Total may not equal the sum of volume, net price, mix/other and currency due to rounding.
(b) Combined impact of changes in volume, net price and mix/other.
(c) Combined benefits of the FORCE (Focused On Reducing Costs Everywhere) program and 2018 Global Restructuring Program.
(d) Includes impact of changes in product mix, marketing, research and general expenses, foreign currency transaction effects and other manufacturing costs.
Net sales of $4.6 billion in the first quarter of 2019 decreased 2 percent compared to the year-ago period. Changes in foreign currency exchange rates reduced sales by 5 percent. Organic sales increased 3 percent. Changes in net selling prices increased sales by approximately 4 percent and changes in product mix increased sales by 1 percent, while sales volumes fell about 2 percent. In North America, organic sales increased 1 percent in both consumer products and K-C Professional. Outside North America, organic sales rose 7 percent in D&E markets and 1 percent in developed markets.
Operating profit in the first quarter was $655 in 2019 and $247 in 2018. Results in both periods include charges related to the 2018 Global Restructuring Program. First quarter adjusted operating profit was $807 in 2019 and $824 in 2018. Results were impacted by $135 of higher input costs, driven by $60 in pulp and $45 in other raw materials. In addition, foreign currency translation effects reduced operating profit by $25 and transaction effects also negatively impacted the comparison. Advertising spending also increased year-on-year. Results benefited from higher net selling prices, $60 of cost savings from the 2018 Global Restructuring Program and $55 of cost savings from our FORCE program.
The first quarter effective tax rate was 24.6 percent in 2019 and 59.8 percent in 2018, which included an $82 net charge associated with U.S. tax reform related matters. The first quarter adjusted effective tax rate was 23.7 percent in 2019 and 22.0 percent in 2018. The rate in 2018 benefited from the resolution of certain tax matters.
Our share of net income of equity companies in the first quarter was $27, even with the year-ago period. Results were impacted by higher input costs, but benefited from organic sales growth and cost savings.
Diluted net income per share for the first quarter of 2019 was $1.31. First quarter adjusted earnings per share were $1.66 in 2019, a decrease of 3 percent compared to adjusted earnings per share of $1.71 in 2018.

17



Results by Business Segments
Personal Care
 
 
Three Months Ended March 31
 


 
Three Months Ended March 31
 
 
2019
 
2018
 
 
 
2019
 
2018
Net Sales
 
$
2,275

 
$
2,307

 
Operating Profit
 
$
484

 
$
470

 
 
 
 
 
 
 
 
 
 
 
Net Sales
 
Percent Change
 
Operating Profit
 
Percent Change
Volume
 
1

 
Volume
 
4

Net Price
 
2

 
Net Price
 
12

Mix/Other
 
1

 
Input Costs
 
(13
)
Currency
 
(6
)
 
Cost Savings(c)
 
16

Total(a)
 
(1
)
 
Currency Translation
 
(4
)
 
 
 
 
Other(d)
 
(12
)
Organic(b)
 
5

 
Total
 
3

(a) Total may not equal the sum of volume, net price, mix/other and currency due to rounding.
(b) Combined impact of changes in volume, net price and mix/other.
(c) Combined benefits of the FORCE program and 2018 Global Restructuring Program.
(d) Includes impact of changes in product mix, marketing, research and general expenses, foreign currency transaction effects and other manufacturing costs.
First quarter net sales of $2.3 billion decreased 1 percent. Changes in foreign currency exchange rates reduced sales by 6 percent. Changes in net selling prices increased sales approximately 2 percent, sales volumes rose 1 percent and changes in product mix improved sales by 1 percent. First quarter operating profit of $484 increased 3 percent. The comparison benefited from organic sales growth and cost savings, while results were impacted by unfavorable foreign currency effects, input cost inflation and increased advertising spending.
Net sales in North America increased 3 percent driven by higher sales volumes. Volumes were up high-single digits in adult care, including benefits from category growth, innovations and increased marketing support. Volumes increased low-single digits in baby and child care.
Net sales in D&E markets decreased 5 percent. Changes in foreign currency exchange rates decreased sales by 13 percent, including significant declines in Latin America. Changes in net selling prices and product mix increased sales by 8 percent and 2 percent, respectively, while sales volumes fell 2 percent. The higher net selling prices were primarily in Latin America and secondarily in the Middle East/Eastern Europe/Africa, partially offset by decreases in China. The lower volumes included declines in China and Argentina, and increases in Eastern Europe and ASEAN.
Net sales in developed markets outside North America decreased 6 percent, including a 6 percent decrease due to unfavorable changes in foreign currency exchange rates. Changes in net selling prices decreased sales by 3 percent, while sales volumes increased 2 percent.

18



Consumer Tissue
 
 
Three Months Ended March 31
 


 
Three Months Ended March 31
 
 
2019
 
2018
 
 
 
2019
 
2018
Net Sales
 
$
1,526

 
$
1,579

 
Operating Profit
 
$
241

 
$
249

 
 
 
 
 
 
 
 
 
 
 
Net Sales
 
Percent Change
 
Operating Profit
 
Percent Change
Volume
 
(6
)
 
Volume
 
(14
)
Net Price
 
6

 
Net Price
 
35

Mix/Other
 

 
Input Costs
 
(18
)
Currency
 
(3
)
 
Cost Savings(c)
 
8

Total(a)
 
(3
)
 
Currency Translation
 

 
 
 
 
Other(d)
 
(14
)
Organic(b)
 

 
Total
 
(3
)
(a) Total may not equal the sum of volume, net price, mix/other and currency due to rounding.
(b) Combined impact of changes in volume, net price and mix/other.
(c) Combined benefits of the FORCE program and 2018 Global Restructuring Program.
(d) Includes impact of changes in marketing, research and general expenses, foreign currency transaction effects and other manufacturing costs.
First quarter net sales of $1.5 billion decreased 3 percent. Changes in foreign currency exchange rates reduced sales 3 percent. Changes in net selling prices increased sales by 6 percent, while sales volumes decreased 6 percent compared to a 7 percent increase in the base period. First quarter operating profit of $241 decreased 3 percent. The comparison was impacted by lower volumes, input cost inflation, other manufacturing cost increases and unfavorable foreign currencies, while results benefited from increased net selling prices and cost savings.
Net sales in North America decreased 3 percent. Changes in net selling prices increased sales by 7 percent, while sales volumes fell 10 percent compared to a 9 percent increase in the prior year. The volume decline reflects lower promotion activity, the impact of price increases and a severe cold and flu season in the year-ago period that benefited facial tissue sales.
Net sales in D&E markets decreased 4 percent. Changes in foreign currency exchange rates decreased sales by 8 percent, primarily in Latin America. Changes in net selling prices and product mix increased sales by 5 percent and 1 percent, respectively, while sales volumes fell 2 percent.
Net sales in developed markets outside North America decreased 5 percent. Changes in foreign currency exchange rates reduced sales by 6 percent. Changes in net selling prices increased sales by 4 percent and sales volumes fell 3 percent, with the changes mostly in Western/Central Europe.

19



K-C Professional
 
 
Three Months Ended March 31
 


 
Three Months Ended March 31
 
 
2019
 
2018
 
 
 
2019
 
2018
Net Sales
 
$
817

 
$
832

 
Operating Profit
$
150

 
$
158

 
 
 
 
 
 
 
 
 
 
 
Net Sales
 
Percent Change
 
Operating Profit
 
Percent Change
Volume
 
(1
)
 
Volume
 
2

Net Price
 
3

 
Net Price
 
13

Mix/Other
 
1

 
Input Costs
 
(18
)
Exited Businesses(e)
 
(1
)
 
Cost Savings(c)
 
12

Currency
 
(4
)
 
Currency Translation